Follow
Ryan J. Weiss
Title
Cited by
Cited by
Year
Targeting heparin and heparan sulfate protein interactions
RJ Weiss, JD Esko, Y Tor
Organic & biomolecular chemistry 15 (27), 5656-5668, 2017
1432017
PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens
PN Spahn, T Bath, RJ Weiss, J Kim, JD Esko, NE Lewis, O Harismendy
Scientific reports 7 (1), 15854, 2017
852017
ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis
RJ Weiss, PN Spahn, AG Toledo, AWT Chiang, BP Kellman, J Li, ...
Proceedings of the National Academy of Sciences 117 (17), 9311-9317, 2020
472020
Small molecule antagonists of cell-surface heparan sulfate and heparin–protein interactions
RJ Weiss, PLSM Gordts, D Le, D Xu, JD Esko, Y Tor
Chemical science 6 (10), 5984-5993, 2015
282015
Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease
A Basu, NG Patel, ED Nicholson, RJ Weiss
American Journal of Physiology-Cell Physiology 322 (5), C849-C864, 2022
232022
Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate
RJ Weiss, PN Spahn, AWT Chiang, Q Liu, J Li, KM Hamill, S Rother, ...
Nature chemical biology 17 (6), 684-692, 2021
212021
Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
SM Alavi Naini, C Yanicostas, R Hassan-Abdi, S Blondeel, M Bennis, ...
Translational neurodegeneration 7, 1-9, 2018
192018
The prolyl-tRNA synthetase inhibitor halofuginone inhibits SARS-CoV-2 infection
DR Sandoval, TM Clausen, C Nora, AP Cribbs, A Denardo, AE Clark, ...
bioRxiv, 2021.03. 22.436522, 2021
132021
Rearrangement of 3-membered 1, 1, 2-trifluorobromonium and iodonium ions and comparison of trifluorochloronium to fluorocarbenium ions
DF Shellhamer, KJ Davenport, HK Forberg, MP Herrick, RN Jones, ...
The Journal of Organic Chemistry 73 (12), 4532-4538, 2008
92008
Drug-induced oedema
C Schindler, SM Schellong
Phlebologie 38 (01), 33-41, 2009
62009
TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth
A Basu, RN Champagne, NG Patel, ED Nicholson, RJ Weiss
Journal of Biological Chemistry 299 (6), 2023
22023
Glycosaminoglycan Analysis: Purification, Structural Profiling, and GAG–Protein Interactions
A Basu, RJ Weiss
Chemokine-Glycosaminoglycan Interactions: Methods and Protocols, 159-176, 2022
22022
Correction to: Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
SMA Naini, C Yanicostas, R Hassan-Abdi, S Blondeel, M Bennis, ...
Translational Neurodegeneration 9, 1-2, 2020
12020
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis
D Calhoon, L Sang, D Bezwada, N Kim, A Basu, SC Hsu, A Pimentel, ...
bioRxiv, 2024
2024
Antithrombin heparan sulfate for detection and treatment of cancer
R Weiss, TM Clausen, JD Esko
US Patent App. 18/257,838, 2024
2024
Heparan sulfate modified proteins affect cellular processes central to neurodegeneration and modulate presenilin function
N Schultheis, A Connell, A Kapral, RJ Becker, R Mueller, S Shah, ...
bioRxiv, 2024.01. 23.576895, 2024
2024
Exploring the Regulatory Mechanisms of EXT1 and EXT2 for Identifying Drug Targets in Multiple Hereditary Exostoses (MHE)
X Dong, K Suryadevara, L Wells, R Weiss
GLYCOBIOLOGY 33 (11), 958-958, 2023
2023
Drug Discovery for Sanfilippo Syndrome
A Basu, M Intermann, BC Maloney, K Cisneros, AC Russell, CA Rice, ...
GLYCOBIOLOGY 33 (11), 957-957, 2023
2023
High Throughput Drug Discovery for Multiple Hereditary Exostoses
K Cisneros, M Intemann, H Takeuchi, AC Russell, C Rice, RJ Weiss
GLYCOBIOLOGY 33 (11), 957-957, 2023
2023
EZH2 is a Novel Epigenetic Regulator of Heparan Sulfate Biosynthesis
N Patel, A Basu, E Spector, R Champagne, E Nicholson, R Weiss
GLYCOBIOLOGY 33 (11), 1032-1032, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20